伴有孤立性5q缺失的骨髓增生异常综合征（5q-综合征）。一种以核糖体生物合成缺陷为特征的克隆性干细胞疾病。 - Suppr

Suppr

超能文献

Myelodysplastic syndrome with isolated 5q deletion (5q- syndrome). A clonal stem cell disorder characterized by defective ribosome biogenesis.

作者信息

Cazzola Mario

出版信息

Haematologica. 2008 Jul;93(7):967-72. doi: 10.3324/haematol.13377.

DOI:10.3324/haematol.13377

PMID:18591621

Abstract

摘要

相似文献

Myelodysplastic syndrome with isolated 5q deletion (5q- syndrome). A clonal stem cell disorder characterized by defective ribosome biogenesis.

Haematologica. 2008 Jul;93(7):967-72. doi: 10.3324/haematol.13377.

Immunomodulatory drugs in the treatment of myelodysplastic syndromes.

Curr Opin Oncol. 2007 Nov;19(6):656-9. doi: 10.1097/CCO.0b013e3282f0e12b.

The role of lenalidomide in the treatment of patients with chromosome 5q deletion and other myelodysplastic syndromes.

Curr Opin Hematol. 2007 Mar;14(2):123-9. doi: 10.1097/MOH.0b013e328016847a.

Fluorescence in situ hybridization improves the detection of 5q31 deletion in myelodysplastic syndromes without cytogenetic evidence of 5q-.

Haematologica. 2008 Jul;93(7):1001-8. doi: 10.3324/haematol.13012.

A delayed yet durable response to very short lenalidomide therapy and unexpected clone redistribution in a case of myelodysplastic syndrome with del(5q) and del(20q).

Leuk Res. 2009 Nov;33(11):e199-202. doi: 10.1016/j.leukres.2009.06.009. Epub 2009 Jul 9.

Pathophysiology and treatment of the myelodysplastic syndrome with isolated 5q deletion.

Haematologica. 2010 Mar;95(3):348-51. doi: 10.3324/haematol.2009.019141.

Telomere shortening, clonal evolution and disease progression in myelodysplastic syndrome patients with 5q deletion treated with lenalidomide.

Leukemia. 2012 Feb;26(2):356-8. doi: 10.1038/leu.2011.193. Epub 2011 Jul 29.

Myelodysplastic syndromes with del(5q): indications and strategies for cytogenetic testing.

Cancer Genet Cytogenet. 2008 Dec;187(2):101-11. doi: 10.1016/j.cancergencyto.2008.08.002.

Very short-term lenalidomide treatment associated with durable resolution of anemia in a patient with myelodysplastic syndrome with chromosome 5q deletion.

Ann Hematol. 2012 Feb;91(2):309-10. doi: 10.1007/s00277-011-1263-7. Epub 2011 May 28.

[The 5q- syndrome].

Rev Prat. 2010 Dec 20;60(10):1420-2.

引用本文的文献

Genome sequencing in the management of myelodysplastic syndromes and related disorders.

Haematologica. 2025 Feb 1;110(2):312-329. doi: 10.3324/haematol.2023.284947.

Durable response to lenalidomide in a patient with myelodysplastic syndrome associated with isolated 5q deletion and V617F mutation despite discontinuation of treatment.

Mol Clin Oncol. 2016 Jul;5(1):23-26. doi: 10.3892/mco.2016.866. Epub 2016 Apr 20.

Efficacy and safety of lenalidomide in patients with myelodysplastic syndrome with chromosome 5q deletion.

Ther Adv Hematol. 2012 Apr;3(2):105-16. doi: 10.1177/2040620711435659.

Important genes in the pathogenesis of 5q- syndrome and their connection with ribosomal stress and the innate immune system pathway.

Leuk Res Treatment. 2012;2012:179402. doi: 10.1155/2012/179402. Epub 2012 Feb 13.

Unimpaired terminal erythroid differentiation and preserved enucleation capacity in myelodysplastic 5q(del) clones: a single cell study.

Haematologica. 2010 Mar;95(3):398-405. doi: 10.3324/haematol.2009.012773. Epub 2009 Oct 8.

Flow cytometry immunophenotyping for diagnosis of myelodysplastic syndrome.

Haematologica. 2009 Aug;94(8):1041-3. doi: 10.3324/haematol.2009.007682.

The response to lenalidomide of myelodysplastic syndrome patients with deletion del(5q) can be sequentially monitored in CD34+ progenitor cells.

Haematologica. 2009 Mar;94(3):430-1. doi: 10.3324/haematol.13865. Epub 2009 Jan 30.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验